EU-Japan Biotech & Pharma Partnering Conference 2025 to Take Place in Osaka ー Gateway to Japan and Asia’s Life Sciences Market

Osaka Prefecture, in cooperation with the EU-Japan Centre for Industrial Cooperation and the Enterprise Europe Network, will host the EU-Japan Biotech & Pharma Partnering Conference 2025

Why Osaka?

Known as Japan’s “pharmaceutical city” for more than 400 years, Osaka is home to global pharmaceutical companies, innovative startups, universities, and cutting-edge research facilities. Supported by strong industry-academia-government collaboration, Osaka offers international companies a direct gateway to the Japanese and broader Asian biotech and pharma markets.

Event Details

Format & Program: One-to-one partnering meetings, presentations, poster displays.

On-Site Conference:
Monday, 6 October 2025, 9:00–19:00 (JST),
Hotel Hankyu International (4F Shion & 6F Zuicho),Osaka.

Registration closes 30 September. No on-site registration available.

Online Partnering:
Wednesday, 24 – Friday, 26 September 2025 via b2match (no installation required).

Early registration is strongly recommended; same-day registration is possible but approval may take time.

Participation Fee: Free (advance registration required).

Who Should Attend

The conference is open to companies, research and educational institutions, and related organizations in the following fields:

• Drug discovery and drug discovery support (including AI and software tools)
  
  
• Regenerative medicine (including cell and gene therapies)
  
  
• Digital therapeutics (digital technologies for prevention, diagnosis, and treatment, as well as digital–pharma and digital–device combinations)

Eligible participants include organizations based in Japan, EU Member States, Iceland, Norway, Liechtenstein, Albania, Bosnia & Herzegovina, Kosovo, Montenegro, North Macedonia, Serbia, Türkiye, Moldova, and Ukraine.

Registration

Please apply via the official conference site:
EU-Japan Biotech & Pharma Partnering Conference 2025 Registration